RxDoctor Payments Data

Bethany Lussier, MD

Critical Care Medicine · Dallas, TXNPI 1740419878

Payments from drug & device makers

$711in general payments, 2019–2025

Across 10 payments — averaging $71.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$408
  • AstraZeneca$106
  • Sarepta Therapeutics, Inc.$83
  • Breas Medical, Inc.$50
  • Inari Medical, Inc.$32
  • Inspire Medical Systems, Inc.$16
  • plus $16 from 1 others
$14,584in research payments, 2019–2025

Across 8 payments — averaging $1823.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$15K

What the payments were for

  • Food & beverage$711100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim4$408
AstraZeneca1$106
Sarepta Therapeutics, Inc.1$83
Breas Medical, Inc.1$50
Inari Medical, Inc.1$32
Inspire Medical Systems, Inc.1$16
3b Medical, Inc.1$16

How this compares

$711 in reported general payments places this provider in the 55th percentile of 507 critical care medicine providers in Texas.

See all critical care medicine providers in Texas

Medicare billing

Part B allowed, 2024
$34,128
Medicare patients
131
Services billed
281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →